argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
27 dec 2024 - 06:00
Statutory name
argenx SE
Title
argenx Announces Approval of VYVDURA (efgartigimod alfa and hyaluronidase-qvfc) in Japan for Adults with Chronic Inflammatory Demyelinating Polyneuropathy
Date last update: 18 August 2025